237 related articles for article (PubMed ID: 12463740)
1. T cell memory, anergy and immunotherapy in breast cancer.
Schirrmacher V; Feuerer M; Beckhove P; Ahlert T; Umansky V
J Mammary Gland Biol Neoplasia; 2002 Apr; 7(2):201-8. PubMed ID: 12463740
[TBL] [Abstract][Full Text] [Related]
2. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
[TBL] [Abstract][Full Text] [Related]
3. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.
Feuerer M; Beckhove P; Bai L; Solomayer EF; Bastert G; Diel IJ; Pedain C; Oberniedermayr M; Schirrmacher V; Umansky V
Nat Med; 2001 Apr; 7(4):452-8. PubMed ID: 11283672
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial.
Domschke C; Ge Y; Bernhardt I; Schott S; Keim S; Juenger S; Bucur M; Mayer L; Blumenstein M; Rom J; Heil J; Sohn C; Schneeweiss A; Beckhove P; Schuetz F
Cancer Immunol Immunother; 2013 Jun; 62(6):1053-60. PubMed ID: 23595207
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
Schuetz F; Ehlert K; Ge Y; Schneeweiss A; Rom J; Inzkirweli N; Sohn C; Schirrmacher V; Beckhove P
Cancer Immunol Immunother; 2009 Jun; 58(6):887-900. PubMed ID: 18998129
[TBL] [Abstract][Full Text] [Related]
6. The immune response to breast cancer, and the case for DC immunotherapy.
Allan CP; Turtle CJ; Mainwaring PN; Pyke C; Hart DN
Cytotherapy; 2004; 6(2):154-63. PubMed ID: 15203992
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory.
Schirrmacher V
Cancer Immunol Immunother; 2005 Jun; 54(6):587-98. PubMed ID: 15838708
[TBL] [Abstract][Full Text] [Related]
8. Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.
Beckhove P; Feuerer M; Dolenc M; Schuetz F; Choi C; Sommerfeldt N; Schwendemann J; Ehlert K; Altevogt P; Bastert G; Schirrmacher V; Umansky V
J Clin Invest; 2004 Jul; 114(1):67-76. PubMed ID: 15232613
[TBL] [Abstract][Full Text] [Related]
9. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
[TBL] [Abstract][Full Text] [Related]
10. Vaccine studies demonstrate promise of immunotherapy to treat breast cancer and prevent recurrence.
Oncology (Williston Park); 2000 Oct; 14(10):1415-6. PubMed ID: 11098507
[No Abstract] [Full Text] [Related]
11. Injecting Hope--A Review of Breast Cancer Vaccines.
Mittendorf EA; Peoples GE
Oncology (Williston Park); 2016 May; 30(5):475-81, 485. PubMed ID: 27188680
[TBL] [Abstract][Full Text] [Related]
12. Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells.
Koido S; Tanaka Y; Tajiri H; Gong J
Vaccine; 2007 Mar; 25(14):2610-9. PubMed ID: 17239504
[TBL] [Abstract][Full Text] [Related]
13. Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients.
Domschke C; Schuetz F; Sommerfeldt N; Rom J; Scharf A; Sohn C; Schneeweiss A; Beckhove P
Cancer Immunol Immunother; 2010 Mar; 59(3):479-86. PubMed ID: 19957084
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in breast cancer: Current status and future directions.
Basu A; Ramamoorthi G; Jia Y; Faughn J; Wiener D; Awshah S; Kodumudi K; Czerniecki BJ
Adv Cancer Res; 2019; 143():295-349. PubMed ID: 31202361
[TBL] [Abstract][Full Text] [Related]
15. Progress in Vaccine Therapies for Breast Cancer.
Li X; Bu X
Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
[TBL] [Abstract][Full Text] [Related]
16. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA
J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients.
Bai L; Koopmann J; Fiola C; Fournier P; Schirrmacher V
Int J Oncol; 2002 Oct; 21(4):685-94. PubMed ID: 12239606
[TBL] [Abstract][Full Text] [Related]
18. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4
Lacher MD; Bauer G; Fury B; Graeve S; Fledderman EL; Petrie TD; Coleal-Bergum DP; Hackett T; Perotti NH; Kong YY; Kwok WW; Wagner JP; Wiseman CL; Williams WV
Front Immunol; 2018; 9():776. PubMed ID: 29867922
[TBL] [Abstract][Full Text] [Related]
19. Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II).
Gold JE; Bleiweiss IJ; Goldfarb AB; Bauer JJ; Gelernt IM; Schwartz ME; Reiner MA; Miller CM; Weiss MF; Brower ST
J Surg Oncol; 1994 Apr; 55(4):222-8. PubMed ID: 8159004
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of breast cancer.
Wright SE
Expert Opin Biol Ther; 2012 Apr; 12(4):479-90. PubMed ID: 22413825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]